Merus N.V.

Merus N.V. - Current Ratioverified

MRUS

Price:

$90

Market Cap:

$6.83B

Merus N.V. is a clinical-stage immuno-oncology firm based in the Netherlands, specializing in the discovery and advancement of bispecific antibody therapies. Established in 2003, the company maintains its headquarters in Utrecht. Its robust pipeline of bispecific antibody candidates includes Zenocutuzumab (MCLA-128), which is currently undergoing Phase 2 clinical trials for the treatment of patients with metastatic breast cancer, and is also in Phase 1/2 clinical trials for solid tumors that exhibit Neuregulin 1 expression. Merus is also actively developing several other compounds: MCLA-158: In Phase 1 clinical trials for solid tumors. MCLA-145: Also in Phase 1 clinical trials for various so...[Read more]

Industry

Biotechnology

IPO Date

2016-05-19

Stock Exchange

NASDAQ

Ticker

MRUS

The Current Ratio as of June 2026 (TTM) for Merus N.V. (MRUS) is 7.97

According to Merus N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 7.97. This represents a change of 10.89% compared to the average of 7.19 of the last 4 quarters.

Merus N.V. (MRUS) Historical Current Ratio (quarterly & annually)

How has MRUS Current Ratio performed in the past?

The mean historical Current Ratio of Merus N.V. over the last ten years is 6.45. The current 7.97 Current Ratio has changed 12.26% with respect to the historical average. Over the past ten years (40 quarters), MRUS's Current Ratio was at its highest in in the March 2017 quarter at 17.02. The Current Ratio was at its lowest in in the March 2023 quarter at 3.44.

Quarterly (TTM)
Annual

Average

6.45

Median

6.22

Minimum

3.88

Maximum

10.05

Merus N.V. (MRUS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Merus N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 811.25%

Maximum Annual Current Ratio = 10.05

Minimum Annual Increase = -34.19%

Minimum Annual Current Ratio = 3.88

Quarterly (TTM)
Annual
YearCurrent RatioChange
20246.5422.43%
20235.3437.49%
20223.88-34.19%
20215.9026.51%
20204.66-30.65%
20196.72-0.41%
20186.75-32.81%
201710.059.57%
20169.1767.84%
20155.46811.25%

Merus N.V. (MRUS) Average Current Ratio

How has MRUS Current Ratio performed in the past?

The current Current Ratio of Merus N.V. (MRUS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.25

5-year avg

5.26

10-year avg

6.45

Merus N.V. (MRUS) Current Ratio vs. Peers

How is MRUS’s Current Ratio compared to its peers?

Merus N.V.’s Current Ratio is greater than Cytokinetics, Incorporated (4.21), less than Nuvalent, Inc. (16.14), less than Abivax S.A. (8.75), greater than Axsome Therapeutics, Inc. (1.39), greater than Metsera, Inc. (4.25), greater than Rhythm Pharmaceuticals, Inc. (4.17), greater than Jazz Pharmaceuticals plc (2.04), greater than Halozyme Therapeutics, Inc. (2.76), greater than Corcept Therapeutics Incorporated (2.86), less than Atrium Therapeutics, Inc. (13.04),

Build a custom stock screener for Merus N.V. (MRUS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Merus N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Merus N.V. (MRUS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Merus N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Merus N.V.'s Current Ratio?

How is the Current Ratio calculated for Merus N.V. (MRUS)?

What is the highest Current Ratio for Merus N.V. (MRUS)?

What is the 3-year average Current Ratio for Merus N.V. (MRUS)?

What is the 5-year average Current Ratio for Merus N.V. (MRUS)?

How does the current Current Ratio for Merus N.V. (MRUS) compare to its historical average?